Membrane Protein Research Group, Departments of 1 Physiology and 2 Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada T6G 2H7; and 3 School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The human concentrative (Na+-linked) plasma membrane transport proteins hCNT1, hCNT2, and hCNT3 are pyrimidine nucleoside-selective (system cit), purine nucleoside-selective (system cif), or broadly selective for both pyrimidine and purine nucleosides (system cib), respectively. All have orthologs in other mammalian species and belong to a gene family (CNT) that has members in insects, nematodes, pathogenic yeast, and bacteria. Here, we report the cDNA cloning and functional characterization of a CNT family member from an ancient marine prevertebrate, the Pacific hagfish (Eptatretus stouti). This Na+-nucleoside symporter, designated hfCNT, is the first transport protein to be characterized in detail in hagfish and is a 683-amino acid residue protein with 13 predicted transmembrane helical segments (TMs). hfCNT was 52, 50, and 57% identical in sequence to hCNT1, hCNT2, and hCNT3, respectively. Similarity to hCNT3 was particularly marked in the TM 4-13 region. When produced in Xenopus oocytes, hfCNT exhibited the transport properties of system cib, with uridine, thymidine, and inosine apparent Km values of 10-45 µM. The antiviral nucleoside drugs 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyinosine were also transported. Simultaneous measurement of uridine-evoked currents and radiolabeled uridine uptake under voltage-clamp conditions gave a Na+-to-uridine coupling ratio of 2:1 (cf. 2:1 for hCNT3 and 1:1 for hCNT1/2). The apparent K50 value for Na+ activation was >100 mM. A 50:50 chimera between hfCNT and hCNT1 (TMs 7-13 of hfCNT replaced by those of hCNT1) exhibited hCNT1-like cation interactions, establishing that the structural determinants of cation stoichiometry and binding affinity were located within the carboxy-terminal half of the protein. The high degree of sequence similarity between hfCNT and hCNT3 may indicate functional constraints on the primary structure of the transporter and suggests that cib-type CNTs fulfill important physiological functions.
Craniata; Xenopus oocyte; 3'-azido-3'-deoxythymidine; 2',3'-dideoxycytidine; 2',3'-dideoxyinosine
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
MOST NATURAL AND synthetic nucleosides are hydrophilic and require specialized nucleoside transport (NT) proteins for passage across cell membranes (6, 15). NT-mediated transport is therefore a critical determinant of intracellular nucleoside metabolism and the pharmacological actions of antineoplastic and antiviral nucleoside drugs (1, 31). By modulating the concentration of adenosine in the vicinity of cell surface receptors, NTs also have important physiological effects on neurotransmission, vascular tone, and other processes (10, 38). Five major nucleoside transport processes that differ in their cation dependence, permeant selectivities, and inhibitor sensitivities have been observed in human and other mammalian cells and tissues (6, 15).1 Three are concentrative (Na+ dependent) (systems cit, cif, and cib) and two are equilibrative (Na+ independent) (systems es and ei). The former are found primarily in specialized epithelia such as intestine, kidney, liver, choroid plexus, and leukemic cells, whereas the latter are present in most, possibly all, cell types (1, 6, 15). Systems cit and cif transport adenosine and uridine but are otherwise pyrimidine or purine nucleoside selective, respectively. Systems cib, es, and ei are broadly selective for both pyrimidine and purine nucleosides. The ei system also transports nucleobases (51).
Molecular cloning studies have isolated cDNAs encoding the human proteins responsible for each of these NT processes (cit, cif, cib, es, ei) (8, 16, 17, 35-37, 44). These proteins and their orthologs in other mammalian species (5, 26, 35, 48, 49) comprise two new, previously unrecognized families of integral membrane proteins designated CNT (concentrative nucleoside transporter family) and ENT (equilibrative nucleoside transporter family). The relationships of these NT proteins to the processes defined by functional studies are as follows: CNT1 (cit), CNT2 (cif), CNT3 (cib), ENT1 (es), and ENT2 (ei). The two protein families are unrelated and have different membrane architectures (22, 40), mammalian CNTs having 13 predicted transmembrane helices (TMs) with an intracellular amino terminus and an exofacial glycosylated tail at the carboxy terminus (22). NupC, a CNT family member from Escherichia coli, has a similar membrane topology to mammalian CNTs but lacks TMs 1-3 (22).
Human (h) CNT1 contains 650 amino acid residues and is 83% identical in sequence to rat (r) CNT1 (648 residues) (26, 36). hCNT2 (658 residues) is 83% identical to rCNT2 (659 residues) and 72% identical to hCNT1 (5, 37, 44, 49). hCNT3 (691 residues) is 78% identical to rCNT3 and mouse (m) CNT3 (both 703 residues) and ~50% identical to h/rCNT1 and h/rCNT2 (35).2 These CNTs are unrelated to SNST1 (now SGLT2), a previous candidate cib-type nucleoside transport protein from rabbit kidney (34), and mutagenesis of amino acid residues in TMs 7 and 8 of hCNT1 has been shown to sequentially change the specificity of the transporter from cit to cib to cif (30). While CNTs have been most thoroughly characterized in mammals (and E. coli), recent genome sequencing projects have revealed that putative CNT family members are also widely distributed in lower eukaryotes, including insects (Drosophila melanogaster), nematodes (Caenorhabditis elegans), and pathogenic yeast (Candida albicans).
Hagfish (Hyperotreti) are eel-like jawless marine animals that diverged from the main line of vertebrate evolution ~550 million years ago (2, 14, 27, 39). They are the most ancient extant member of the subphylum Craniata, which includes humans and other vertebrates, having evolved from animals that represent the transition between early chordates and the first true vertebrates. As such, hagfish represent a unique research resource in molecular studies of early vertebrate evolution. Hagfish plasma is in approximate osmotic equilibrium with sea water (500 mM NaCl), and studies with their red blood cells have revealed a number of novel membrane transport characteristics (11, 13, 41, 52-54). Although these investigations have provided functional insights into hagfish membrane transport biology, there is little known structurally about hagfish transport proteins. In fact, the GenBank database lists only their mitochondrion genome and 14 complete hagfish cDNA sequences, including that of a hagfish equilibrative glucose transport protein (hfGLUT) (see footnote 2).
In this report, we describe the first hagfish transport protein to be characterized in detail at the molecular level. hfCNT, a member of the CNT family, exhibited strong cib-type transport activity when produced in Xenopus oocytes. Differences in cation interactions between hfCNT and hCNT1 were exploited in a chimeric study to demonstrate that determinants of the Na+ binding and coupling were located within the carboxy-terminal half of the protein.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Molecular cloning of hfCNT.
The cDNA encoding hfCNT was obtained by first amplifying a partial
hfCNT cDNA. The template was a directional Stratagene lambda vector
Uni-ZAP XR cDNA library prepared in this laboratory using mRNA isolated
from hagfish intestinal tissue (mucosal scrapings). Two rounds of
nested PCR were employed using a pair of internal primers against
regions of conserved sequence among mammalian and bacterial CNTs: Q1
(antisense; rCNT1 nucleotide sequence 5'-TTTGCCAACTTCAGATCCATCGGG-3' corresponding to motif FANFSSIG in TM12) and Q2 (sense; hCNT1 nucleotide sequence 5'-AACATCGCTGCCAACCTGATTGC-3' corresponding to
motif NIAANLIA in TM10). Initial amplification of diluted (1,000-fold) hagfish phage cDNA library with Q2 as the sense primer and T7 oligonucleotide sequence corresponding to a region of the Uni-ZAP XR
insertion vector downstream of the XhoI cloning site as the antisense primer involved 1 cycle of 94°C for 5 min,
56°C for 1 min and 72°C for 1 min 30 s, 33 cycles of 94°C for 1 min, 56°C for 1 min and 72°C for 1 min 30 s, and a final extension
cycle at 72°C for 10 min. A portion (10%) of the
first-round PCR product was then subjected to a second round of
amplification with Q1 and Q2 for 28 cycles under the same conditions. A
366-bp product was identified, cloned into pGEM-T vector (Promega), and
sequenced by Taq dyedeoxyterminator cycle sequencing using
an automated model 373A DNA Sequencer (Applied Biosystems). This
fragment, which showed 61, 62, and 39% sequence identity to the
corresponding regions of hCNT1, rCNT1, and NupC, respectively, was
radiolabeled with 32P (T7QuickPrime kit;
Amersham Pharmacia Biotech) and used as a hybridization probe to screen
the hagfish intestinal cDNA library. Ten positive clones were
identified, three of which contained full-length hfCNT cDNA. One of
these clones in Uni-ZAP XR vector was excised to generate a subclone in
the pBluescript SK vector according to the manufacturer's
instructions. This 2.5-kb subclone was sequenced in both directions to
give a 683-amino acid residue open reading frame flanked by 21 bp of
untranslated 5'-nucleotide sequence and 443 bp of untranslated
3'-nucleotide sequence containing a poly(A)+ tail.
Other hagfish CNTs. The presence of transcripts for other possible CNT isoforms in hagfish intestinal mucosa was tested using a pair of internal primers against regions of amino acid sequence common to hfCNT and human and rat CNT1-3: Q3 (antisense; hfCNT nucleotide sequence 5'-CTCTGCGGTTTTGCTAATTT-3' corresponding to motif LCGFAN in TM12) and Q4 (sense; hfCNT nucleotide sequence 5'-AACCTCATCGCTTTCCTGGC-3' corresponding to motif NLIAFLA in TM10). RT-PCR yielded product of the expected size (~360 bp). This was subcloned into pGEM-T vector. Twelve clones were selected at random and sequenced.
Construction of chimeric hfCNT and hCNT1 transporters. cDNAs of hfCNT and hCNT1 were subcloned into the vector pGEM-HE (39) before chimera construction to enhance expression in Xenopus oocytes. Overlap primers (sense, 5'-TGGCTTATGCAAGTCACCATG-3'; antisense, 5'-GGTACCCATGGTGACTTGCATAAGCCA-3') were designed at a splice site between Gly311 and Trp312 of hfCNT in the loop linking TM 6 and TM 7 (arrow in Fig. 8A) to create reciprocal 50:50 chimeras by a two-step overlap extension PCR method (25) using the universal pUC/M13 forward and reverse primers and high-fidelity Pyrococcus furiosus DNA polymerase. Chimeric constructs containing the restriction site KpnI downstream of the M13 forward primer and the restriction site SphI upstream of the M13 reverse primer were subcloned into the respective restriction sites of the pGEM-HE vector. The chimeras were sequenced in both directions to verify the splice sites and ensure that no mutations had been introduced.
In vitro transcription and expression in Xenopus oocytes. hfCNT and chimeric cDNAs were expressed in Xenopus laevis oocytes according to standard protocols (47). Healthy defolliculated stage VI oocytes of X. laevis were microinjected with 20 nl water or 20 nl water containing RNA transcripts (1 ng/nl) and incubated in modified Barth's medium at 18°C for 72 h before the assay of transport activity.
Radioisotope flux studies. Transport was traced using the appropriate 14C/3H-labeled nucleoside, nucleoside drug, or nucleobase (Moravek Biochemicals or Amersham Pharmacia Biotech) at either 1 or 2 µCi/ml for 14C-labeled and 3H-labeled compounds, respectively. Flux measurements were performed at room temperature (20°C) as described previously (26, 47) on groups of 12 oocytes in 200 µl transport medium containing 100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES, pH 7.5. Unless otherwise indicated, permeant concentrations were 10 µM. At the end of incubation periods, extracellular label was removed by six rapid washes in ice-cold transport medium, and individual oocytes were dissolved in 5% (wt/vol) SDS for quantitation of oocyte-associated radioactivity by liquid scintillation counting (LS 6000 IC; Beckman). Initial rates of transport (influx) were determined using an incubation period of 1 min (26). Choline replaced sodium in Na+-dependence experiments, and the transport medium for adenosine uptake contained 1 µM deoxycoformycin to inhibit adenosine deaminase activity. The flux values shown are means ± SE of 10-12 oocytes, and each experiment was performed at least twice on different batches of cells. Kinetic parameters were determined using programs of the ENZFITTER software package (Elsevier-Biosoft, Cambridge, UK).
Measurement of hfCNT-induced sodium currents.
Membrane currents were measured in voltage-clamped oocytes at room
temperature using the two-electrode voltage clamp (CA-1B oocyte clamp;
Dagan). The microelectrodes were filled with 3 M KCl and had
resistances that ranged from 0.5 to 1.5 M. The CA-1B was interfaced
to a computer via a Digidata 1200B analog-to-digital convertor and
controlled by Axoscope software (Axon Instruments). Current signals
were filtered at 20 Hz (four-pole Bessel filter) and sampled at
intervals of 10 ms. For data presentation, the signals were further
filtered at 0.5 Hz by use of pCLAMP software (Axon Instruments). After
microelectrode penetration, resting membrane potential was measured
over a 15-min period before the start of the experiment. Cells were not
used if the resting membrane potential was unstable or less than
30
mV. For measurements of hfCNT-generated currents, the oocyte membrane
potential was clamped at
50 mV. Oocytes were perfused with the same
medium used for radioisotope flux studies, and transport was initiated
by changing substrate-free solution to one containing nucleoside (200 µM). In experiments examining Na+ and H+
dependence, sodium in the medium was replaced by choline, and pH was
varied from 5.5 to 8.5. For the determination of the charge-to-uridine uptake ratio, currents were monitored and recorded after an oocyte was
clamped at
50 mV in substrate-free transport medium for a 10-min
period. The solution was then exchanged with transport medium of the
same composition containing radiolabeled uridine. Current was measured
for 3 min, followed immediately by reperfusion with substrate-free
transport medium until current returned to baseline. The oocyte was
recovered from the chamber and solubilized with 5% SDS for liquid
scintillation counting. The total movement of charge across the plasma
membrane was calculated by integrating the uridine-evoked current over
the uptake period. Charge was converted into picomoles to compare with
radiolabeled uridine uptake. Uptake of 14C-labeled uridine
in control H2O-injected oocytes was used to correct for
endogenous basal uptake of uridine over the same incubation period. The
coupling ratio of hfCNT was calculated from data collected from 10 individual oocytes.
![]() |
RESULTS AND DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Previous studies of nucleoside transport in hagfish have been limited to red blood cells, which possess an equilibrative nitrobenzylthioinosine (NBMPR)-insensitive (ei-type) nucleoside transport process (13). The goal of the present study was to use recombinant DNA technology in combination with heterologous expression in Xenopus oocytes to attempt the cDNA cloning and functional characterization of a hagfish concentrative nucleoside transport protein.
Molecular identification of hfCNT.
The first step of our cDNA cloning strategy exploited regions of amino
acid sequence similarity between CNT family members to isolate a
partial-length hagfish CNT cDNA from intestinal epithelium, a tissue in
mammals known to express multiple CNT proteins (6). The
template for this PCR amplification was a cDNA library prepared from
hagfish intestinal mucosa. The resulting 366-bp fragment generated by
PCR amplification (see EXPERIMENTAL PROCEDURES) was used as
a probe to screen our hagfish intestinal cDNA library. High-stringency
hybridization screening yielded a 2,516-bp cDNA, with an open reading
frame of 2,049 bp flanked by 21 bp of 5'-untranslated region and 446 bp
of 3'-untranslated region containing a poly(A)+ tail. The
encoded 683-amino acid residue protein, designated hfCNT (Fig.
1A),
with 13 predicted TMs, had a putative molecular mass of 76 kDa and was
52% identical (62% similar) to hCNT1, 50% identical (59% similar)
to hCNT2, and 57% identical (67% similar) to hCNT3. In addition to
having multiple consensus sites for N-linked glycosylation
at the carboxy terminus (Asn625, Asn630,
Asn652, Asn660, Asn670), hfCNT also
contained an additional potential site of glycosylation on the putative
extracellular loop between TMs 9 and 10 (Asn411) (Fig.
1A). The extracellular location of the carboxy terminus has
been confirmed by mutagenesis of rCNT1, which is glycosylated at
Asn605 and Asn643 (22).
|
Other hagfish CNTs. Human and rat intestine contain transcripts for all three mammalian concentrative nucleoside transporters (CNT1-3). We therefore searched for other possible CNT isoforms in hagfish intestine using hfCNT primers corresponding to regions of amino acid sequence in TMs 10 and 12 identical in hfCNT and human and rat CNT1-3. Twelve randomly selected RT-PCR clones were sequenced. Each contained a 363-bp insert identical in nucleotide sequence to the corresponding region of hfCNT, establishing hfCNT as the major CNT transcript present in hagfish intestine.
Production of recombinant hfCNT in Xenopus oocytes.
Mammalian CNT1 and CNT2 display pyrimidine nucleoside-selective
cit-type and purine nucleoside-selective cif-type
transport activities, respectively. hfCNT, in contrast, was found to be similar to human, mouse, and rat CNT3 and to mediate
cib-type transport of both pyrimidine and purine
nucleosides. Figure 2 shows
representative time courses for uptake of uridine (a universal CNT1/2/3
permeant), thymidine (a diagnostic CNT1 permeant), and inosine (a
diagnostic CNT2 permeant) in oocytes injected with either hfCNT RNA
transcript or water. After 30 min, the uptake values of uridine,
thymidine, and inosine in hfCNT-producing oocytes were 37 ± 6, 58 ± 6, and 62 ± 8 pmol/oocyte, respectively, 95- to
380-fold higher than those in water-injected oocytes (0.2-0.4 pmol/oocyte). Substitution of Na+ in the incubation medium
by choline reduced the fluxes in RNA-injected oocytes by 98%. In the
subsequent kinetic experiments (presented in Figs. 4 and 6), we used a
1-min incubation period to define initial rates of uridine, thymidine,
and inosine uptake.
|
Substrate selectivity and antiviral drug transport of recombinant
hfCNT.
Figure 3 shows a representative transport
experiment in Xenopus oocytes that measured uptake of a
panel of radiolabeled pyrimidine and purine nucleosides in cells
injected with water alone (control) or water containing hfCNT
transcripts. Consistent with cib-type functional activity,
hfCNT-producing oocytes transported all the pyrimidine and purine
nucleosides tested (cytidine, thymidine, uridine, adenosine,
deoxyadenosine, guanosine, and inosine) and gave similar mediated
fluxes (uptake in RNA-injected oocytes minus uptake in water-injected
oocytes) for each nucleoside tested (18 ± 3, 22 ± 2, 17 ± 3, 24 ± 5, 22 ± 3, 21 ± 3, and 14 ± 2 pmol · oocyte1 · 30 min
1,
respectively). In contrast, no mediated transport of uracil was
detected, establishing the transporter's specificity for nucleosides over nucleobases.
|
Kinetic properties.
Figure 4 presents representative
concentration dependence curves for uridine, inosine, and thymidine
transport, measured as initial rates of uptake (1-min fluxes) in
hfCNT-producing oocytes and in control water-injected oocytes. Kinetic
constants for the hfCNT-mediated component of uptake are presented in
Table 1. Apparent Michaelis constant
(Km) values for uridine, inosine, and thymidine
transport were similar (10, 35, and 45 µM, respectively) and in the
same range as values obtained previously for recombinant mammalian
CNT1/2/3 proteins (5, 8, 26, 36, 37, 44, 49). Maximum
velocity (Vmax) values for the three nucleosides were similar. Influx of uridine, inosine, and thymidine in control, water-injected oocytes was linear with concentration, consistent with
nonmediated simple diffusion across the lipid layer.
|
|
hfCNT Na+-nucleoside cotransport. In mammalian cells, most plasma membrane transporters use the sodium electrochemical gradient to actively transport substrates into or out of cells, whereas in bacteria, H+ is the preferred ion of many coupled transporters (23). A few mammalian transporters have been described that use H+ as the coupling ion, including oligopeptide transporters (32), iron transporters (18), monocarboxylate transporters (19), and a myo-inositol transporter (43). The three mammalian CNTs function as Na+-dependent nucleoside transporters, although recent electrophysiological studies in Xenopus oocytes have found that H+ and Li+ can substitute for Na+ for CNT3, but not for CNT1 or CNT2 (unpublished data). In contrast, Na+ replacement and pH-dependence experiments suggest that C. albicans CaCNT (unpublished data), C. elegans CeCNT3 (46), and E. coli NupC (47) are exclusively H+ dependent. In the case of CaCNT, this has been confirmed by electrophysiology (unpublished data).
As shown in Figure 5, external application of adenosine, cytidine, guanosine, inosine, thymidine, or uridine (200 µM) to hfCNT-producing oocytes generated quantitatively similar inward currents that returned to baseline upon removal of permeant. No currents were seen in water-injected oocytes or when Na+ in the extracellular medium was replaced by choline, confirming that hfCNT3 functions as an electrogenic Na+/nucleoside symporter. In addition, no uridine-mediated currents were detected under Na+-free conditions over the pH range 5.5-8.5, indicating that hfCNT was unable to substitute H+ for Na+ (data not shown). A similar negative result was obtained when Li+ was substituted for Na+ (data not shown). Therefore, the CNT protein family includes members that are H+ dependent (CaCNT, CeCNT3, NupC), Na+ dependent (hfCNT, CNT1, CNT2), and Na+/H+ (and Li+) dependent (CNT3). In prokaryotes, the melibiose transporter of E. coli can also use either H+ or Na+ as the coupling ion, depending on which sugar is being transported (3), while that of Klebsiella pneumoniae couples sugar transport to H+ and Li+ (20). On the basis of sequence comparisons between the E. coli and K. pneumoniae proteins, site-directed mutagenesis identified a single residue in TM 2 that was important for Na+ recognition (21). Because hfCNT and hCNT3 are very similar in amino acid sequence, particularly in the region from TM4 to TM13 (Fig. 1A), it is likely that introduction of point mutations into hfCNT by site-directed mutagenesis will identify individual amino acid residues that contribute to CNT cation specificity.
|
|
|
Characterization of hfCNT/hCNT1 chimeras. Previously, we have identified two adjacent pairs of residues (Ser319/Gln320 and Ser353/Leu354) in the TM 7-9 region of hCNT1 that, when mutated together to the corresponding residues in hCNT2 (Gly313/Met314 and Thr347/Val348), converted hCNT1 (cit type) into a transporter with cif-type functional characteristics (30). An intermediate broad specificity cib-like transport activity was produced by mutation of the two TM 7 residues alone. The amino acid residues of hfCNT at these four positions are Gly335/Gln336 in TM7 and Ser369/Val370 in TM8, which represents the intermediate state between hCNT1 and hCNT2 to allow transport of both purine and pyrimidine nucleosides. In addition to differing in substrate specificity, we have shown in the previous section that hfCNT and hCNT1 also exhibit differences in interactions with Na+, the hagfish transporter having a Na+/nucleoside coupling ratio of 2:1 (vs. 1:1 for hCNT1) and a high K50 value for Na+ activation of >100 mM.
The predicted amino acid sequences of hfCNT and hCNT1 are 52% identical and 62% similar, with strongest residue similarity within TMs of the carboxy-terminal halves of the proteins. The major differences lie in the putative amino- and carboxy-terminal tails of the proteins and in the first three TMs (Fig. 8A). To localize domains involved in cation stoichiometry and binding affinity, a chimera (HF/H) in which the carboxy-terminal half of hfCNT (incorporating TMs 7-13) was replaced with that of hCNT1 was constructed. The splice site between the two proteins following hfCNT residue Gly311 was engineered at the beginning of the putative extramembraneous loop before TM 7 to divide the proteins into two approximately equal halves as predicted by the topology model in Fig. 8A, and to minimize disruption of native TMs and loops. The resulting chimera (HF/H) transported uridine when produced in Xenopus oocytes (Fig. 8B) but displayed lower levels of functional activity than hfCNT and hCNT1 (most likely the result of reduced plasma membrane targeting) and required a longer incubation period (30 min vs. 1 min) to obtain comparable levels of total uptake. A reciprocal chimera to HF/H (H/HF, a 50:50 construct incorporating the amino-terminal half of hCNT1 and the carboxy-terminal half of hfCNT) was nonfunctional and was not studied further.
|
|
Conclusions. Nucleosides are important precursors of nucleic acids and energy-rich cellular metabolites, and one (adenosine) has functions as a local hormone in a variety of tissues, including the gastrointestinal system (1, 6, 15). Cells obtain nucleosides from breakdown of dietary and endogenous nucleotides. The former are important nutrients and are absorbed as nucleosides by enterocytes of the intestinal mucosa. In mammals, enterocytes have a limited capacity for de novo nucleotide synthesis and require both dietary and endogenous nucleosides for their own metabolism and differentiation (6). hfCNT is a CNT nucleoside transport protein from hagfish intestinal epithelium that belongs to the CNT3 subfamily. hfCNT was electrogenic, Na+ dependent, H+ and Li+ independent, and exhibited a broad permeant selectivity for both pyrimidine and purine nucleosides. hfCNT had a 2:1 Na+/nucleoside coupling stoichiometry, identifying this characteristic, in addition to cib-type substrate selectivity, as a general functional feature of the hfCNT/CNT3 subfamily. A two-Na+/one-nucleoside symporter such as hfCNT will have greater ability to transport permeant against its concentration gradient than a one-Na+/one-nucleoside symporter, particularly when considered in the context of the very high concentration of Na+ present in hagfish extracellular fluids or intestinal lumen and the high K50 value for hfCNT Na+ activation. hfCNT differed from its mammalian orthologs in that it was unable to substitute H+ (and Li+) for Na+.
The differences in cation stoichiometry, binding affinity, and specificity between hfCNT and mammalian CNTs will provide a basis for future site-directed mutagenesis studies to identify the amino acid residues involved. Although there is greater sequence divergence between hfCNT and CNT1/2 than between hfCNT and CNT3, our functionally active hfCNT/hCNT1 chimera HF/H has narrowed down the region of interest to the carboxy-terminal halves of the proteins. Within TMs 7-13, there are only 51 residue differences between hfCNT and hCNT1 that could potentially account for the observed differences in the Na+/nucleoside coupling ratio and binding affinity. Many of these residue differences occur in clusters, making it feasible to undertake multiple simultaneous mutations between the two proteins to rapidly identify the amino acid residues involved. Hagfish (Hyperotreti) are prevertebrates that diverged from the main line of vertebrate evolution about 550 million years ago and represent the most ancient extant member of the craniate subphylum. The fossil record indicates that hagfish have undergone little evolutionary change in body structures (39). In the phylogenetic analysis of functionally characterized CNT family members shown in Fig. 1B, hfCNT clustered with mammalian CNT3 proteins. Since the period around the Hyperotreti-Vertebrata split was a time of very active gene duplication (33), it will be informative from an evolutionary perspective to establish in future studies whether or not hagfish also contain members of the CNT1/2 subfamily. The present finding by RT-PCR that hfCNT is the predominant CNT in hagfish intestine may indicate the absence of other concentrative nucleoside transporter isoforms and contrasts with mammalian intestine which contains transcripts for CNT1, CNT2, and CNT3 (35-37). Even in the absence of other CNTs, the functional characteristics described here for hfCNT would enable the efficient intestinal absorption of both pyrimidine and purine dietary nucleosides required by their scavenging carnivorous life-style and periodic feeding behavior. The high degree of amino acid sequence similarity between hfCNT and mammalian CNT3 proteins, particularly in the TM 4-13 region, may indicate functional constraints on the primary structure of this region and provides structural evidence that cib-type nucleoside transporters fulfill important physiological functions. ![]() |
ACKNOWLEDGEMENTS |
---|
This research was funded by the Natural Sciences and Engineering Research Council of Canada, The National Cancer Institute of Canada, and the Alberta Cancer Board. S. A. Baldwin's work is supported by the Medical Research Council of the United Kingdom. S. K. Loewen is funded by a studentship from the Alberta Heritage Foundation for Medical Research. J. D. Young is a Heritage Scientist of the Alberta Heritage Foundation for Medical Research. C. E. Cass holds a Canada Research Chair in Oncology at the University of Alberta.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: J. D. Young, Dept. of Physiology, 7-55 Medical Sciences Building, Univ. of Alberta, Edmonton, Alberta, Canada T6G 2H7 (E-mail: james.young{at}ualberta.ca).
2 GenBank/EBI Data Bank accession numbers: AF132298 (hfCNT), AY059413 (hfGLUT), and AY059414 (rCNT3).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Abbreviations used in transporter acronyms are as follows: c, concentrative; e, equilibrative; s and i, sensitive and insensitive to inhibition by nitrobenzylthioinosine, respectively; f, formycin B (nonmetabolized purine nucleoside); t, thymidine; g, guanosine; b, broad selectivity.
First published February 20, 2002;10.1152/ajpcell.00587.2001
Received 10 December 2001; accepted in final form 14 February 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Baldwin, SA,
Mackey JR,
Cass CE,
and
Young JD.
Nucleoside transporters: molecular biology and implications for therapeutic development.
Mol Med Today
5:
216-224,
1999[ISI][Medline].
2.
Bardack, D.
First fossil hagfish (Myxinoidea): a record from the Pensylvanian of Illinois.
Science
254:
701-703,
1991[ISI].
3.
Botfield, MC,
Wilson DM,
and
Wilson TH.
The melibiose carrier of Escherichia coli.
Res Microbiol
141:
328-331,
1990[ISI][Medline].
4.
Cass, CE.
Nucleoside transport.
In: Drug Transport in Antimicrobial and Anticancer Chemotherapy. New York: Dekker, 1995, p. 404-451.
5.
Che, M,
Ortiz DF,
and
Arias IM.
Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na+-nucleoside cotransporters.
J Biol Chem
270:
13596-13599,
1995
6.
Cheeseman, CI,
Mackey JR,
Cass CE,
Baldwin SA,
and
Young JD.
Molecular mechanism of nucleoside and nucleoside drug transport. Gastrointestinal transport.
In: A Volume of Current Topics in Membranes. San Diego, CA: Academic, 2000, p. 330-379.
7.
Chen, XZ,
Shayakul C,
Berger UV,
Tian W,
and
Hediger MA.
Characterization of a rat Na+-dicarboxylate cotransporters.
J Biol Chem
273:
20972-20981,
1998
8.
Crawford, CR,
Patel DH,
Naeve C,
and
Belt JA.
Cloning of a human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
J Biol Chem
273:
5288-5293,
1998
9.
Diez-Sampedro, A,
Eskandari S,
Wright EM,
and
Hirayama BA.
Na+-to-sugar stoichiometry of SGLT3.
Am J Physiol Renal Physiol
280:
F278-F282,
2001
10.
Dunwiddle, TV,
and
Masino SA.
The role and regulation of adenosine in the central nervous system.
Annu Rev Neurosci
24:
31-55,
2001[ISI][Medline].
11.
Ellory, JC,
and
Wolowyk MW.
Evidence for bumetanide-sensitive, Na+-dependent, partial Na-K-Cl co-transport in red blood cells of a primitive fish.
Can J Physiol Pharmacol
69:
588-591,
1991[ISI][Medline].
12.
Felsentein, J.
Phylip-phylogeny inference package (version 3.2).
Cladistics
5:
164-166,
1989.
13.
Fincham, DA,
Wolowyk MW,
and
Young JD.
Nucleoside uptake by red blood cells from a primitive vertebrate, the Pacific hagfish (Eptatretus stouti), is mediated by a nitrobenzylthioinosine-insensitive transport system.
Biochim Biophys Acta
1069:
123-126,
1991[ISI][Medline].
14.
Forey, PL,
and
Janvier P.
Agnathans and the origin of jawed vertebrates.
Nature
361:
129-134,
1993[ISI].
15.
Griffith, DA,
and
Jarvis SM.
Nucleoside and nucleobase transport systems of mammalian cells.
Biochim Biophys Acta
1286:
153-181,
1996[ISI][Medline].
16.
Griffiths, M,
Beaumont N,
Yao SYM,
Sundaram M,
Bouman CE,
Davies A,
Kwong FYP,
Coe IR,
Cass CE,
Young JD,
and
Baldwin SA.
Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs.
Nat Med
3:
89-93,
1997[ISI][Medline].
17.
Griffiths, M,
Yao SYM,
Abidi F,
Phillips SEV,
Cass CE,
Young JD,
and
Baldwin SA.
Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
Biochem J
328:
739-743,
1997[ISI][Medline].
18.
Gunshin, H,
MacKenzie B,
Berger UV,
Gunshin Y,
Romero MF,
Boron WF,
Nussberger S,
Gollan JL,
and
Hediger MA.
Cloning and characterization of a mammalian proton-coupled metal-ion transporter.
Nature
388:
482-488,
1997[ISI][Medline].
19.
Halestrap, AP,
and
Price NT.
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation.
Biochem J
343:
281-299,
1999[ISI][Medline].
20.
Hama, H,
and
Wilson TH.
Primary structure and characteristics of the melibiose carrier of Klebsiella pneumoniae.
J Biol Chem
267:
18371-18376,
1992
21.
Hama, H,
and
Wilson TH.
Replacement of alanine 58 by asparagines enables the melibiose carrier of Klebsiella pneumoniae to couple sugar transport to Na+.
J Biol Chem
269:
1063-1067,
1994
22.
Hamilton, SR,
Yao SYM,
Ingram JC,
Hadden DA,
Ritzel MWL,
Gallagher MP,
Henderson PJ,
Cass CE,
Young JD,
and
Baldwin SA.
Subcellular distribution and membrane topology of the mammalian concentrative Na+-nucleoside cotransporters rCNT1.
J Biol Chem
276:
27981-27988,
2001
23.
Hediger, MA.
Structure, function and evolution of solute transporters in prokaryotes and eukaryotes.
J Exp Biol
196:
15-49,
1994
24.
Hong, M,
Schlichter L,
and
Bendayan R.
A novel zidovudine uptake system in microglia.
J Pharmacol Exp Ther
292:
366-374,
2000
25.
Horton, RM,
Hunt HD,
Ho SN,
Pullen JK,
and
Pease LR.
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.
Gene
77:
51-59,
1989[ISI][Medline].
26.
Huang, QQ,
Yao SYM,
Ritzel MWL,
Paterson ARP,
Cass CE,
and
Young JD.
Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein.
J Biol Chem
269:
17757-17760,
1994
27.
Janvier P. Tree of life: hyperotreti (online). University of
Arizona.
http://phylogeny.arizona.edu/tree/eukaryotes/animals/chordata/hyperotreti/hyperotreti.html
(2001, Sept 19).
28.
Kaback, HR,
Satin-Tóth M,
and
Weinglass AB.
The Kamikaze approach to membrane transport.
Nat Rev Mol Cell Biol
2:
610-620,
2001[ISI][Medline].
29.
Liman, ER,
Tytgat J,
and
Hess P.
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
Neuron
9:
861-871,
1992[ISI][Medline].
30.
Loewen, SK,
Ng AM,
Yao SY,
Cass CE,
Baldwin SA,
and
Young JD.
Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na+ nucleoside cotransporters hCNT1 and hCNT2.
J Biol Chem
274:
24475-24484,
1999
31.
Mackey, JR,
Baldwin SA,
Young JD,
and
Cass CE.
Nucleoside transport and its significance for anticancer drug resistance.
Drug Resistance Updates
1:
310-324,
1998[ISI].
32.
Meredith, D,
and
Boyd CA.
Structure and function of eukaryotic peptide transporters.
Cell Mol Life Sci
57:
754-778,
2000[ISI][Medline].
33.
Ono-Koyanagi, K,
Suga H,
Katoh K,
and
Miyata T.
Protein tyrosine phosphatases from amphioxus, hagfish, and ray: divergence of tissue-specific isoform genes in the early evolution of vertebrates.
J Mol Evol
50:
302-311,
2000[ISI][Medline].
34.
Pajor, AM,
and
Wright EM.
Cloning and functional expression of a mammalian Na+-nucleoside cotransporters. A member of the SGLT family.
J Biol Chem
267:
3557-3560,
1992
35.
Ritzel, MWL,
Ng AML,
Yao SYM,
Graham K,
Loewen SK,
Smith KM,
Ritzel RG,
Mowles DA,
Carpenter P,
Chen X-Z,
Karpinski E,
Hyde RJ,
Baldwin SA,
Cass CE,
and
Young JD.
Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporters proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
J Biol Chem
276:
2914-2927,
2001
36.
Ritzel, MWL,
Yao SYM,
Huang MY,
Elliot JF,
Cass CE,
and
Young JD.
Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporters (hCNT1).
Am J Physiol Cell Physiol
272:
C707-C714,
1997
37.
Ritzel, MWL,
Yao SYM,
Ng AML,
Mackey JR,
Cass CE,
and
Young JD.
Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+ nucleoside cotransporters (hCNT2) selective for purine nucleosides and uridine.
Mol Membr Biol
15:
203-211,
1998[ISI][Medline].
38.
Shryock, JC,
and
Belardinelli L.
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology.
Am J Cardiol
79:
2-10,
1997[ISI][Medline].
39.
Shu, D-G,
Luo H-L,
Conway Morris S,
Zhang X-L,
Hu S-X,
Chen L,
Han J,
Zhu M,
Li Y,
and
Chen L-Z.
Lower Cambrian vertebrates from south China.
Nature
402:
42-46,
1999[ISI].
40.
Sundaram, M,
Yao SYM,
Ingram JC,
Bery ZA,
Adidi F,
Cass CE,
Baldwin SA,
and
Young JD.
Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.
J Biol Chem
276:
4520-45275,
2001.
41.
Tiihonen, K,
Yao SYM,
Nikinmaa M,
and
Young JD.
Sodium-dependent transport of pyruvate in erythrocytes of the Pacific hagfish (Eptatretus stouti).
Can J Zool
78:
2019-2026,
2000[ISI].
42.
Thompson, JD,
Gibson TJ,
Plewniak F,
Jeanmougin F,
and
Higgins DG.
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
Nucleic Acids Res
25:
4876-4882,
1997
43.
Uldry, M,
Ibberson M,
Horisberger JD,
Chatton JY,
Riederer BM,
and
Thorens B.
Identification of a mammalian H+-myo-inositol symporter expresses predominantly in the brain.
EMBO J
20:
4467-4477,
2001
44.
Wang, J,
Su SF,
Dresser MJ,
Schaner ME,
Washington CB,
and
Giacomini KM.
Na+-dependent purine nucleoside transporter from human kidney: cloning and functional characterization.
Am J Physiol Renal Physiol
273:
F1058-F1065,
1997
45.
Wu, X,
Yuan G,
Brett CM,
Hui AC,
and
Giacomini KM.
Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides.
J Biol Chem
267:
8813-8818,
1992
46.
Xiao, GQ,
Wang J,
Tangen T,
and
Giacomini KM.
A novel proton-dependent nucleoside transporter, CeCNT3, from Caenorhabiditis elegans.
Mol Pharmacol
59:
339-348,
2001
47.
Yao, SYM,
Cass CE,
and
Young JD.
The Xenopus oocyte expression system for the cDNA cloning and characterization of plasma membrane transport proteins.
In: Membrane Transport. A Practical Approach. Oxford, UK: Oxford Univ. Press, 2000, p. 47-78.
48.
Yao, SYM,
Ng AML,
Muzyka WR,
Griffiths M,
Cass CE,
Baldwin SA,
and
Young JD.
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
J Biol Chem
272:
28423-28430,
1997
49.
Yao, SYM,
Ng AML,
Ritzel MWL,
Gati WP,
Cass CE,
and
Young JD.
Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes.
Mol Pharmacol
50:
1529-1535,
1996[Abstract].
50.
Yao, SYM,
Ng AML,
Sundaram M,
Cass CE,
Baldwin SA,
and
Young JD.
Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, NBMPR-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes.
Mol Membr Biol
18:
161-167,
2001[ISI][Medline].
51.
Yao SYM, Ng AML, Sundaram M, Cass CE, Baldwin SA, and Young JD.
Functional and molecular characterization of nucleobase transport by
recombinant human and rat ENT1 and ENT2 equilibrative nucleoside
transport proteins: chimeric constructs reveal a role for the ENT2
helix 5-6 region in nucleobase translocation. J Biol
Chem. In press.
52.
Young, JD,
Ellory JC,
and
Wolowyk MW.
Hagfish (Eptatretus stouti) erythrocytes show minimal chloride transport activity.
J Exp Biol
129:
377-383,
1987[ISI][Medline].
53.
Young, JD,
Fincham DA,
and
Harvey CM.
Cation and harmaline interactions with Na+-independent dibasic amino acid transport system y+ in human erythrocytes and in erythrocytes from a primitive vertebrate the pacific hagfish (Eptatretus stouti).
Biochim Biophys Acta
1071:
111-118,
1991.
54.
Young, JD,
Yao SYM,
Tse CM,
Davies A,
and
Baldwin SA.
Functional and molecular characteristics of a primitive vertebrate glucose transporter: studies of glucose transport by erythrocytes from the pacific hagfish (Eptatretus stouti).
J Exp Biol
186:
23-41,
1994